UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

The New England journal of medicine, 2011-07, Vol.365 (1), p.32-43

2011

Volltextzugriff (PDF)

819 Does a Low Ejection Fraction Predict Mortality? Insights From the ASCEND-HF Trial

Canadian journal of cardiology, 2012-09, Vol.28 (5), p.S413-S414

2012

Volltextzugriff (PDF)

The PROTECT In-Hospital Risk Model: 7-Day Outcome in Patients Hospitalized with Acute Heart Failure (AHF) and Renal Dysfunction

Journal of cardiac failure, 2011, Vol.17 (8), p.S77-S77

2011

Volltextzugriff (PDF)

Mode of death in heart failure: findings from the ATLAS trial

British heart journal, 2003-01, Vol.89 (1), p.42-48

2003

Volltextzugriff (PDF)

Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial

European heart journal, 2000-12, Vol.21 (23), p.1967-1978

2000

Volltextzugriff (PDF)

Regional differences in patient characteristics in an international heart failure trial

Journal of the American College of Cardiology, 1998, Vol.31, p.114-115

1998

Volltextzugriff (PDF)

Management of heart failure. II. Counseling, education, and lifestyle modifications

JAMA : the journal of the American Medical Association, 1994-11, Vol.272 (18), p.1442

1994

Volltextzugriff (PDF)

Reduced hospitalizations and health care costs by an interactive home monitoring program for heart failure patients

Journal of the American College of Cardiology, 1998, Vol.31, p.115-115

1998

Volltextzugriff (PDF)

H21 The antihypertensive effects of the selective T-type calcium channel blocker mibefradil: A double-blind comparison with diltiazem CD

American journal of hypertension, 1997-04, Vol.10 (S2), p.82A-82A

1997

Volltextzugriff (PDF)

Aspirin Use in Chronic Heart Failure: What Should We Recommend to the Practitioner?

ACC current journal review, 2005-12, Vol.14 (12), p.24-24

Massie, B.M.

2005

Volltextzugriff (PDF)

Improved regional ventricular function after successful surgical revascularization

Journal of the American College of Cardiology, 1984-04, Vol.3 (4), p.902-908

1984

Volltextzugriff (PDF)

P058 Evaluating hypertension control in a large HMO

American journal of hypertension, 1998-04, Vol.11 (S3), p.225A-225A

1998

Volltextzugriff (PDF)

Warfarin and antiplatelet therapy study in chronic heart failure (WATCH): Trial design

Journal of cardiac failure, 1999-09, Vol.5 (3), p.48-48

1999

Volltextzugriff (PDF)

Tolerabilidad de elevadas dosis de IECA en pacientes con insuficiencia cardíaca congestiva. Resultados del estudio ATLAS

Hipertensión y riesgo vascular, 2001, Vol.18 (5), p.255-255

2001

Volltextzugriff (PDF)

Historical perspectives in educational psychology, with particular reference to the training of teachers

Massie, B.M

1980

Volltextzugriff (PDF)

Usefulness of thallium-201 Scintigraphy in predicting the development of angina pectoris in hypertensive patients with left ventricular hypertrophy

The American journal of cardiology, 1989-07, Vol.64 (1), p.45-49

1989

Volltextzugriff (PDF)

326 Anaemia is associated with poor outcome in patients with heart failure and preserved ejection fraction (HF-PEF). Findings from the I-PRESERVE trial

European journal of heart failure. Supplements, 2008-06, Vol.7 (Suppl_1), p.86-86

2008

Volltextzugriff (PDF)

36 Diabetes is associated with increased risk of CV events in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Systolic Function Trial

European journal of heart failure. Supplements, 2008-06, Vol.7 (Suppl_1), p.2-2

2008

Volltextzugriff (PDF)

To Combat Hypertension, Increase Activity

The Physician and sportsmedicine, 1992-05, Vol.20 (5), p.88-111

Massie, Barry M.

1992

Volltextzugriff (PDF)

500 Effects of the selective A1 adenosine receptor antagonist KW-3902 in the treatment of patients with acute heart failure, congestion and renal impairment: rationale and design of the study

European journal of heart failure. Supplements, 2007-06, Vol.6 (Suppl), p.111-111

2007

Volltextzugriff (PDF)

229 Effects of rolofylline, a new adenosine A1 receptor antagonist, on symptoms, renal function and outcomes in patients with acute heart failure. Results of the PROTECT pilot study

European journal of heart failure. Supplements, 2008-06, Vol.7 (Suppl_1), p.53-54

2008

Volltextzugriff (PDF)

34 Association of physician-determined worsening heart failure with signs and symptoms, hospitalization duration, and 60-day outcomes in patients hospitalised for acute heart failure

European journal of heart failure. Supplements, 2008-06, Vol.7 (Suppl_1), p.1-1

2008

Volltextzugriff (PDF)

β-blocker therapy for heart failure outside the clinical trial setting: Findings of a community-based registry

ACC current journal review, 2005-02, Vol.14 (2), p.34-34

2005

Volltextzugriff (PDF)

Relationship of regional myocardial perfusion to segmental wall motion: a physiologic basis for understanding the presence and reversibility of asynergy

Circulation (New York, N.Y.), 1978-12, Vol.58 (6), p.1154-1163

1978

Volltextzugriff (PDF)

549 Randomized, double-blind, placebo-controlled trial to assess the impact of darbepoetin alfa treatment on exercise tolerance in anemic patients with symptomatic heart failure: results from STAMINA-HeFT

European journal of heart failure. Supplements, 2006-06, Vol.5 (Suppl), p.122-122

2006

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(29)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

819 Does a Low Ejection Fraction Predict Mortality? Insights From the ASCEND-HF Trial

The PROTECT In-Hospital Risk Model: 7-Day Outcome in Patients Hospitalized with Acute Heart Failure (AHF) and Renal Dysfunction

Mode of death in heart failure: findings from the ATLAS trial

Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial

Regional differences in patient characteristics in an international heart failure trial

Management of heart failure. II. Counseling, education, and lifestyle modifications

Reduced hospitalizations and health care costs by an interactive home monitoring program for heart failure patients

H21 The antihypertensive effects of the selective T-type calcium channel blocker mibefradil: A double-blind comparison with diltiazem CD

Aspirin Use in Chronic Heart Failure: What Should We Recommend to the Practitioner?

Improved regional ventricular function after successful surgical revascularization

P058 Evaluating hypertension control in a large HMO

Warfarin and antiplatelet therapy study in chronic heart failure (WATCH): Trial design

Tolerabilidad de elevadas dosis de IECA en pacientes con insuficiencia cardíaca congestiva. Resultados del estudio ATLAS

Historical perspectives in educational psychology, with particular reference to the training of teachers

Usefulness of thallium-201 Scintigraphy in predicting the development of angina pectoris in hypertensive patients with left ventricular hypertrophy

326 Anaemia is associated with poor outcome in patients with heart failure and preserved ejection fraction (HF-PEF). Findings from the I-PRESERVE trial

36 Diabetes is associated with increased risk of CV events in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Systolic Function Trial

To Combat Hypertension, Increase Activity

500 Effects of the selective A1 adenosine receptor antagonist KW-3902 in the treatment of patients with acute heart failure, congestion and renal impairment: rationale and design of the study

229 Effects of rolofylline, a new adenosine A1 receptor antagonist, on symptoms, renal function and outcomes in patients with acute heart failure. Results of the PROTECT pilot study

34 Association of physician-determined worsening heart failure with signs and symptoms, hospitalization duration, and 60-day outcomes in patients hospitalised for acute heart failure

β-blocker therapy for heart failure outside the clinical trial setting: Findings of a community-based registry

Relationship of regional myocardial perfusion to segmental wall motion: a physiologic basis for understanding the presence and reversibility of asynergy

549 Randomized, double-blind, placebo-controlled trial to assess the impact of darbepoetin alfa treatment on exercise tolerance in anemic patients with symptomatic heart failure: results from STAMINA-HeFT

Suchergebnisse filtern